中文

Untranslated

English
Chinese
French
German
Portuguese
Spanish
Russian
Japanese
Korean
Arabic
Irish
Greek
Turkish
Italian
Danish
Romanian
Indonesian
Czech
Afrikaans
Swedish
Polish
Basque
Catalan
Esperanto
Hindi
Lao
Albanian
Amharic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Bulgarian
Cebuano
Chichewa
Corsican
Croatian
Dutch
Estonian
Filipino
Finnish
Frisian
Galician
Georgian
Gujarati
Haitian
Hausa
Hawaiian
Hebrew
Hmong
Hungarian
Icelandic
Igbo
Javanese
Kannada
Kazakh
Khmer
Kurdish
Kyrgyz
Latin
Latvian
Lithuanian
Luxembou..
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Burmese
Nepali
Norwegian
Pashto
Persian
Punjabi
Serbian
Sesotho
Sinhala
Slovak
Slovenian
Somali
Samoan
Scots Gaelic
Shona
Sindhi
Sundanese
Swahili
Tajik
Tamil
Telugu
Thai
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Kinyarwanda
Tatar
Oriya
Turkmen
Uyghur

More Language

86-21-64556180

cpd-service@caerulumpharma.com

Ile
Nipa re
Awọn ọja
Awọn ojutu
Oro
- Gbigba lati ayelujara
- Aworan aworan
FAQs
Pe wa

Ile
Awọn ọja
Awọn moleku bioactive
Antineoplastic
BCl2-BH4

Awọn ẹka Awọn ọja

Antineoplastic
- ACC
- Adenosine A2A
- ALK
- Androgen receptor inhibitor
- Apoptosis stimulant
- ATR
- AXL
- BCl2-BH4
- Bcr-Abl
- BRAF
- BTK
- CDK
- Chk1
- CYP17
- DNA alkylating oluranlowo
- EED
- EGFR
- EP4
- ER
- FAK
- FGFR
- FLT3
- Glutaminase
- IDO
- IRA
- KIT
- LXR
- MDM2
- MEK
- MET
- Nrf2
- P90RSK
- P97
- PAKS
- PARP
- PI3K
- Plk-1
- SMYD2
- SRC
- TOPK
- VEGFR
Awọn oogun hypoglycemic
- DPP-4
- SGLT-1
- SGLT-2
Awọn miiran
- 5HT
- AMPK
- Arginase
- CRF-1
- CXCR2
- FLAP
- FXR
- GABA
- Gi activator
- GR
- JAK
- LABA
- mAChRs
- NF-κB
- NRTI
- PPAR
- RIP1
- S1PR
- SGC
- SYK
- α2δ-1
- αIIbβ3
- β2-adrenoceptor
- σ1

BCl2-BH4

Ologbo #	Orukọ ọja	Apejuwe
CPD102300	S-55746

o

Pe wa

No. 401, 4th Floor, Building 6, Quwu Road 589, Minhang District, 200241 Shanghai, China
86-21-64556180
Laarin China:
sales-cpd@caerulumpharma.com
Orílẹ̀-èdè:
cpd-service@caerulumpharma.com

Ìbéèrè

Fun awọn ibeere nipa awọn ọja wa, jọwọ fi imeeli rẹ silẹ pẹlu wa ati pe a yoo kan si laarin awọn wakati 24.Ìbéèrè

Awọn irohin tuntun

AstraZeneca gba igbelaruge ilana fun ...

AstraZeneca gba igbelaruge ilọpo meji fun portfolio oncology rẹ ni ọjọ Tuesday, lẹhin AMẸRIKA ati awọn olutọsọna Yuroopu gba awọn ifisilẹ ilana fun awọn oogun rẹ, igbesẹ akọkọ si gbigba ifọwọsi fun awọn oogun wọnyi. ...

Top 7 Awọn aṣa Ni Iwadi elegbogi Ni ọdun 2018

Awọn aṣa 7 ti o ga julọ Ninu Iwadi elegbogi I...

Jije labẹ titẹ ti n pọ si nigbagbogbo lati dije ni eto eto-ọrọ aje ati imọ-ẹrọ ti o nija, awọn ile-iṣẹ elegbogi ati awọn ile-iṣẹ imọ-ẹrọ gbọdọ ṣe imotuntun nigbagbogbo ninu awọn eto R&D wọn lati duro niwaju…

ARS-1620: Oludena tuntun ti o ni ileri fun awọn aarun alakan KRAS-mutant

ARS-1620: Oludena tuntun ti o ni ileri fun K…

Gẹgẹbi iwadi ti a tẹjade ni Cell, awọn oniwadi ti ṣe agbekalẹ kan pato inhibitor fun KRASG12C ti a pe ni ARS-1602 ti o fa ifasẹyin tumo ninu awọn eku. "Iwadi yii pese ni ẹri vivo pe KRAS mutant le jẹ ...

AstraZeneca gba igbelaruge ilana fun ...

AstraZeneca gba igbelaruge ilọpo meji fun portfolio oncology rẹ ni ọjọ Tuesday, lẹhin AMẸRIKA ati awọn olutọsọna Yuroopu gba awọn ifisilẹ ilana fun awọn oogun rẹ, igbesẹ akọkọ si gbigba ifọwọsi fun awọn oogun wọnyi. ...

Awọn aṣa 7 ti o ga julọ Ninu Iwadi elegbogi I...

Jije labẹ titẹ ti n pọ si nigbagbogbo lati dije ni eto eto-ọrọ aje ati imọ-ẹrọ ti o nija, awọn ile-iṣẹ elegbogi ati awọn ile-iṣẹ imọ-ẹrọ gbọdọ ṣe imotuntun nigbagbogbo ninu awọn eto R&D wọn lati duro niwaju…

FAQs
Gbigba lati ayelujara
Pe wa

Firanṣẹ Imeeli

Koodu QR

x

WhatsApp Online iwiregbe!

TOP

Close

Previous Next

Previous Maximize